Skip to main content

Table 6 Liver function impairment grade of patient pre and post DEB-TACE treatment

From: Efficacy and safety profile of drug-eluting beads transarterial chemoembolization by CalliSpheres® beads in Chinese hepatocellular carcinoma patients

Parameters

Baseline (N = 99)

1 week post treatment (N = 91)

1–3 month post treatment (N = 88)

P value*

P value#

ALB (n)

   

< 0.001

0.134

 Grade 0

8

59

76

 Grade 1

10

26

11

 Grade 2

2

6

1

 Grade 3

0

0

0

 Grade 4

0

0

0

TBIL (n)

   

< 0.001

0.643

 Grade 0

67

26

59

 Grade 1

23

36

21

 Grade 2

9

25

6

 Grade 3

0

4

2

 Grade 4

0

0

0

ALT (n)

   

< 0.001

0.614

 Grade 0

76

32

63

 Grade 1

20

37

23

 Grade 2

3

8

2

 Grade 3

0

13

0

 Grade 4

0

1

0

AST (n)

   

< 0.001

0.218

 Grade 0

62

25

54

 Grade 1

35

42

29

 Grade 2

2

12

3

 Grade 3

0

10

2

 Grade 4

0

1

0

  1. Data was presented as count. Comparison among groups was determined by Wilcoxon signed rank sum test. P < 0.05 was considered significant. *P value of liver function related biochemical indexes of patients from baseline to 1 week post treatment. #P value of liver function related biochemical indexes of patients from baseline to 1–3 month post treatment. ALB Albumin, TBIL Total bilirubin, ALT Alanine aminotransferase, AST Aspartate aminotransferase
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us